Abstract: A compound comprising a first ligand LA of Formula I, In Formula I, moiety B is a monocyclic ring or a polycyclic fused ring system; X1, X2, and Z1 are C or N; Y1 is O, S, Se, Te, CRR?, SiRR?, GeRR?, PR, AsR, SbR, or BiR; K1 is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); each R, R?, R?, R?, RA, and RB is hydrogen or a general substituent; any two substituents may be joined or fused to form a ring; LA is coordinated to a metal M to form a 5-membered or 6-membered chelate ring; and two RB substituents join to form a 5-membered ring if Y1 is O, S, or Se. Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: A compound comprising a ligand of LA of Formula I, is provided with variables as defined herein. Formulations, OLEDs, and consumer products including the compound are also disclosed.

Abstract: Provided are transition metal compounds having 1,2,3-triazine. Also provided are formulations comprising these transition metal compounds having 1,2,3-triazine. Further provided are OLEDs and related consumer products that utilize these transition metal compounds having 1,2,3-triazine.

Abstract: Provided are organometallic compounds comprising iridium as a central metal atom which is coordinated by two three-dentate ligands which each comprise at least three 5-membered or 6-membered rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, moiety A is a 5-membered or 6-membered ring; moiety B is a fused ring structure comprising at least four rings; K is a direct bond, O, or S; each of Z1 and Z2 is independently C or N; each RA and RB is independently hydrogen or a General Substituent; at least one RB comprises a cyclic group or an electron-withdrawing group; LA is coordinated to a metal M that has an atomic mass of at least 40 and is optionally coordinated to other ligands; and the ligand LA is optionally linked with other ligands. Formulations, OLEDs, and consumer products including the compound are also provided.

Abstract: Disclosed are support-activators and catalyst compositions comprising the support-activators for polymerizing olefins in which the support-activator includes clay heteroadduct, prepare from a colloidal phyllosilicate such as a colloidal smectite clay, which is chemically-modified with a heterocoagulation agent. By limiting the amount of heterocoagulation reagent relative to the colloidal smectite clay as described herein, the smectite heteroadduct support-activator is a porous and amorphous solid which can be readily isolated from the resulting slurry by a conventional filtration process, and which can activate metallocenes and related catalysts toward olefin polymerization. Related compositions and processes are disclosed.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, K is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); each of X1 to X8 is C or N; Y is a linking group; each R?, R?, R, R?, R?, R1, RA, RB, and RC is hydrogen or a General Substituent; at least one RC is R*; R* has a structure of Cy-R**, where Cy is a monocyclic ring or a polycyclic fused ring system, which can be further substituted, and R** comprises (i) at least one electron-withdrawing group, (ii) a monocyclic ring or a polycyclic fused ring system, where the monocyclic ring and each ring of the polycyclic fused ring system is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring, or (iii) both (i) and (ii); and LA is coordinated to a metal. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y wherein: ligand LA has Formula I? ?and ligand LC has Formula II?

Abstract: An integrated driving device is provided. The integrated driving device includes a touch sensing circuit and an optical sensing circuit. The touch sensing circuit is configured to perform touch sensing in a plurality of touch sensing periods during a first frame period. The optical sensing circuit is configured to perform optical sensing during at least one optical sensing period during the first frame period to obtain optical sensing signals for generating first ambient light information. The touch sensing periods and the optical sensing period are non-overlapping. Correspondingly, an operation method of an integrated driving device is also provided.

Abstract: Provided are compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications. Also provided are formulations comprising these compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications. Further provided are OLEDs and related consumer products that utilize these compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, rings A and B are 5- or 6-membered ring; K1 and K2 are each independently selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); Z1, Z2, X1 and X2 are C or N; Y1*, Y2*, Y1*, Y4*, and Y5* are selected from a variety of moieties; n is 0 or 1; Y5* is bonded directly to X2 when n is 0; each Ra, R?, R, R?, R1, R2, RA, and RB is hydrogen or a substituent; each independently represents a single bond or double bond in a Lewis structure; and LA is coordinated to a metal M, which may be coordinated to other ligands Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, and a structure of Formula II, is provided. Formula II is fused to ring A by two adjacent ones of X1 to X4, which are both C. In Formula I and II, X1 to X4 are C or N; K is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); moiety E is H or D; C1 is C; each of moiety B and moiety C is independently a ring or a fused ring system; each R?, R?, RA, RB, and RC is hydrogen or a General Substituent; and LA is coordinated to a metal M with an atomic mass of at least 40. If moiety C is a 6-membered ring, then moiety B is a fused ring system and then all the RC substituents comprise two or more of combined carbon atoms. Formulations, OLEDs, and consumer product including the compound are also provided.

Abstract: Provided is a compound of Formula of Ir(LA)n(LB)m(LC)o, wherein ligand LA has a structure of Formula I, ligand LB has a structure of Formula II, and LC is a bidentate ligand; and wherein n is 1, or 2; m is 1, or 2; o is 0, or 1; and n+m+o=3; and all the remaining variables are defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided is a compound comprising a first ligand LA having a structure of Formula I, wherein the variables are defined herein. Also provided are formulations and products containing a compound comprising a structure of Formula I.

Abstract: A heteroleptic compound of formula Ir(LA)m(LB)n(LC)o, where LA has a structure of Formula I, and LB has Formula II, is provided; and LC is a bidentate ligand. In Formulae I and II, moieties A and D are independently a rings or polycyclic ring systems, one of moiety A and moiety D is coordinated to Ir by a 5-membered ring, and the other is coordinated to Ir by a 6-membered ring; each of X, X1 to X12 is C or N; Y is a linking atom; each RA, RB, RC, RD, and RE is hydrogen or a general substituent; and at least one RD or RE substituent comprises an electron-withdrawing group, or an aryl or heteroaryl substituted with an electron-withdrawing group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y, wherein: ligand LA has Formula I? and ligand LC has Formula II?

Abstract: A compound of a first ligand LA of Formula I, is provided. In Formula I, moieties A and B are each a monocyclic ring or a polycyclic fused-ring system; Z1 to Z4 are each C or N; K is a direct bond, O, or S; each RA and RB is independently a hydrogen or a General Substituent; at least one RA or RB is R*, wherein R* has a structure of Formula II, —L—GeR1R2R3; L is a direct bond or an organic linker; and LA is coordinated to a metal M by the dashed lines; and metal M is selected from Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, or Cu.

Abstract: Disclosed are support-activators and catalyst compositions comprising the support-activators for polymerizing olefins in which the support-activator includes clay heteroadduct, prepare from a colloidal phyllosilicate such as a colloidal smectite clay, which is chemically-modified with a heterocoagulation agent. By limiting the amount of heterocoagulation reagent relative to the colloidal smectite clay as described herein, the smectite heteroadduct support-activator is a porous and amorphous solid which can be readily isolated from the resulting slurry by a conventional filtration process, and which can activate metallocenes and related catalysts toward olefin polymerization. Related compositions and processes are disclosed.

Abstract: A compound having a first ligand LA of Formula I, is provided. In Formula I, Z is C or N; at least one of X1 to X5 is N, and the remainder are C; if X1 is N, then X5 is C; K is selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); each R?, R?, RA and RB is a hydrogen or a General Substituent; LA is coordinated to a metal M; and Ring A coordinates to M through a metal carbene bond. Formulations, OLEDs, and consumer products containing the compound are also provided.